gadoliniumjäämiin
Gadoliniumjäämiin refers to residual amounts of the element gadolinium that may remain in the human body after the administration of gadolinium-based contrast agents (GBCAs). GBCAs are used in magnetic resonance imaging (MRI) to enhance the visibility of internal structures. While designed to be excreted from the body, studies have shown that small amounts of gadolinium can be retained, particularly in tissues like the brain, bone, and skin. This retention is thought to be related to the stability of the gadolinium chelate used in the contrast agent.
The clinical significance of gadolinium deposition is still a subject of ongoing research. Some studies have